Subscribe To
Coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)
– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in ...
November 3, 2023, 12:30 pm
Bridger aerospace: a wildfire stock not on sale
Bridger Aerospace is active in aerial firefighting and wildfire management services, capitalizing on the increasing risk of wildfires globally. The co...
October 10, 2023, 8:14 am
Neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy
Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory interneuron ce...
October 5, 2023, 3:00 pm
Eledon pharmaceuticals announces first participant dosed in phase 2 bestow trial evaluating tegoprubart for the prevention of rejection in kidney transplantation
Trial to assess potential of tegoprubart-based immunosuppression to improve graft function compared to ...
September 5, 2023, 11:00 am
Atossa therapeutics is targeting multiple stages of the breast cancer continuum with oral endoxifen
Atossa Therapeutics Inc (NASDAQ:ATOS) is targeting three different stages of the breast cancer continuum with its proprietary oral form of Endoxifen, ...
August 23, 2023, 1:16 pm
Sana biotechnology: hypoimmune platform might stealth cells
Results from the phase 1 study using SC291 for the treatment of patients with B-cell lymphomas are expected to be released later in 2023. It is said t...
July 9, 2023, 10:09 am
Bitcoin speculators send 35k btc to exchanges in new ‘elation inflow’
STHs, it shows, are more apt to sell en masse during periods of BTC price suppression in order to limit...
June 29, 2023, 8:29 am
China's top diplomat wang yi on the wires after meeting with blinken
China's top diplomat Wang Yi, in meeting with U.S. Secretary of State Blinken:Tweet**WE MUST TAKE A RESPONSIBLE ATTITUDE TOWARD THE PEOPLE, HISTORY AN...
June 19, 2023, 5:46 am
New study confirms consistent risk of myelosuppression across all patients receiving chemotherapy for small cell lung cancer
Real-World Data Show No Association Between Patient Characteristics and Risk of Myelosuppressive Events RESEARCH TRIANGLE PARK, N.C., May 16, 2023 (GL...
May 16, 2023, 11:30 am
Optizmo™ releases new email opt-out infographic
The infographic analyzes hundreds of millions of opt-out requests from 2022 AUSTIN, Texas, May 03, 2023 (GLOBE NEWSWIRE) — OPTIZMO Technologies, the...
May 3, 2023, 5:23 pm
Arbutus provides ab-729 clinical data and ab-161 preclinical data as oral presentations at the global hepatitis summit 2023
Seven patients with cHBV remain off all treatment and continue to maintain low levels of HBV DNA and HBsAg for at least one and half years post- AB-72...
April 27, 2023, 7:20 am
Genprex encouraged by latest reports on novel tumor suppressor
Genprex, Inc. (NASDAQ:GNPX) said independent researchers have reported that the tumor suppression gene ...
April 18, 2023, 11:06 am
Powder fire suppression system market to reach us$ 6.5 bn by 2031: tmr study
Asia Pacific is anticipated to witness significant revenue, owing to rapidly increasing adoption of sophisticated/advanced fire ...
April 14, 2023, 4:00 pm
Bitcoin sees record stock-to-flow miss — btc price model creator brushes off ftx ‘blip’
With BTC price suppression ongoing in light of the FTX scandal, an already bearish trend has only stren...
November 19, 2022, 12:32 pm
Cytodyn touts publication of paper on suppression of human and simian immunodeficiency virus replication with leronlimab
CytoDyn Inc, a late-stage biotechnology company developing its flagship drug leronlimab for multiple indications, has revealed the publication of a p...
April 12, 2022, 11:24 am
Amazon is seeking unionization revote, report says
Amazon has reportedly alleged voter suppression, bribes and threats were used to gain the vote....
April 8, 2022, 10:23 pm
Perimeter solutions: a wide-moat company in a life-saving niche
Perimeter's core fire retardant business has a wide moat, enabling pricing power due to its mission-critical nature, the lack of available substitutes...
April 4, 2022, 5:18 pm
Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients
Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...
February 17, 2022, 11:11 am
Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients
Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...
February 17, 2022, 11:11 am
Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients
Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...
February 17, 2022, 11:11 am